Moors & Cabot, Inc.
- SEC CIK
- 0001607239
- Latest filing
- Aug 10, 2026
BMRN holding history
Biomarin Pharmaceutical Inc in every 13F filed by Moors & Cabot, Inc., including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.
BMRN overviewAll 13F holders of BMRNFull Q2 2026 holdings
- Shares (Q3 2024)
- 0
- Sold out in Q3 2024
- Value
- $0
- % of portfolio
- 0.0%
- Quarters held
- 13
- Since Q2 2021
| Quarter | Shares | Value | % of portfolio | Share change | Action | All holders |
|---|---|---|---|---|---|---|
| Q3 2024 | 0 | $0 | 0.0% | −3,450−100.0% | Sold out | Holders |
| Q2 2024 | 3,450 | $284.0K | <0.1% | −20−0.6% | Reduced | Holders |
| Q1 2024 | 3,470 | $303.1K | <0.1% | +482+16.1% | Added | Holders |
| Q4 2023 | 2,988 | $288.1K | <0.1% | +22+0.7% | Added | Holders |
| Q3 2023 | 2,966 | $262.4K | <0.1% | −1,298−30.4% | Reduced | Holders |
| Q2 2023 | 4,264 | $369.6K | <0.1% | −199−4.5% | Reduced | Holders |
| Q1 2023 | 4,463 | $434.0K | <0.1% | +33+0.7% | Added | Holders |
| Q4 2022 | 4,430 | $458.5K | <0.1% | −37−0.8% | Reduced | Holders |
| Q3 2022 | 4,467 | $379.0K | <0.1% | −1,305−22.6% | Reduced | Holders |
| Q2 2022 | 5,772 | $478.0K | <0.1% | 00.0% | Unchanged | Holders |
| Q1 2022 | 5,772 | $445.0K | <0.1% | −63−1.1% | Reduced | Holders |
| Q4 2021 | 5,835 | $516.0K | <0.1% | +1,200+25.9% | Added | Holders |
| Q3 2021 | 4,635 | $357.0K | <0.1% | +205+4.6% | Added | Holders |
| Q2 2021 | 4,430 | $370.0K | <0.1% | +4,430 | New | Holders |